We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$8.17B
1-Year Est. Return
68.82%
This Fund
S&P 500
This Quarter
Est. Return
+1.37%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$5.76B
AUM Growth
+$32.7M
(+0.57%)
Cap. Flow
+$188M
Cap. Flow
% of AUM
3.27%
Top 10 Holdings %
Top 10 Hldgs %
50.49%
Holding
248
New
70
Increased
46
Reduced
39
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$136M |
| 2 |
Freshpet
FRPT
|
+$91.3M |
| 3 |
Ross Stores
ROST
|
+$81.3M |
| 4 |
Five Below
FIVE
|
+$72.6M |
| 5 |
EXAS
Exact Sciences
EXAS
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$75.6M |
| 2 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$71.5M |
| 3 |
Illumina
ILMN
|
+$62.5M |
| 4 |
AstraZeneca
AZN
|
+$55.2M |
| 5 |
Tractor Supply
TSCO
|
+$51.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.48% |
| 2 | Miscellaneous | 31.17% |
| 3 | Consumer Discretionary | 9.47% |
| 4 | Consumer Staples | 8.21% |
| 5 | Technology | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALPP
101
DELISTED
Alpine 4 Holdings Inc
ALPP
| $4.5M | 0.08% |
+1,012,500
| New | +$5.91M |
|
|
NOVN
102
DELISTED
Novan, Inc. Common Stock
NOVN
| $4.29M | 0.07% |
2,293,000
+985,897
| +75% | +$2.48M |
|
103
Rigel Pharmaceuticals
RIGL
$891M
| $4.07M | 0.07% |
+345,287
| New | +$4.67M |
|
104
Elastic
ESTC
$9.37B
| $3.95M | 0.07% |
+55,000
| New | +$4.37M |
|
|
GTM
105
ZoomInfo Technologies
GTM
$1.12B
| $3.92M | 0.07% |
+94,000
| New | +$3.99M |
|
106
Xeris Biopharma Holdings
XERS
$1.54B
| $3.91M | 0.07% |
2,504,431
-3,319,569
| -57% | -$5.49M |
|
|
MGAM
107
DELISTED
Mobile Global Esports Inc. Common Stock
MGAM
| $3.58M | 0.06% |
+1,886,793
| New | +$7.17M |
|
|
TERN
108
DELISTED
Terns Pharmaceuticals
TERN
| $3.53M | 0.06% |
600,000
+276,984
| +86% | +$1.03M |
|
109
Boxlight
BOXL
$4.21M
| $3.52M | 0.06% |
+3,938
| New | +$3.66M |
|
110
Snap
SNAP
$9.17B
| $3.44M | 0.06% |
+350,000
| New | +$4.07M |
|
111
monday.com
MNDY
$3.58B
| $3.4M | 0.06% |
+30,000
| New | +$3.55M |
|
112
SOBR Safe
SOBR
$2.41M
| $3.35M | 0.06% |
+1,136
| New | +$1.49M |
|
113
Acurx Pharmaceuticals
ACXP
$6.15M
| $3.2M | 0.06% |
+53,300
| New | +$3.99M |
|
114
Greenland Technologies Holding
GTEC
$28.1M
| $3.13M | 0.05% |
+1,177,000
| New | +$4.49M |
|
115
SentinelOne
S
$6.8B
| $3.07M | 0.05% |
+120,000
| New | +$3.15M |
|
116
Twilio
TWLO
$34.6B
| $2.77M | 0.05% |
40,000
-16,000
| -29% | -$1.28M |
|
|
AKTX
117
Akari Therapeutics
AKTX
$22.2M
| $2.7M | 0.05% |
+5,363
| New | +$4.42M |
|
118
MediWound
MDWD
$174M
| $2.66M | 0.05% |
+273,646
| New | +$3.45M |
|
|
COUP
119
DELISTED
Coupa Software Incorporated
COUP
| $2.65M | 0.05% |
+45,000
| New | +$2.95M |
|
|
FRMM
120
Forum Markets
FRMM
$64.4M
| $2.6M | 0.05% |
+1,030
| New | +$3.76M |
|
|
BLRX
121
BioLineRX
BLRX
$12.5M
| $2.59M | 0.04% |
+69,926
| New | +$3.99M |
|
|
KAL
122
DELISTED
Kalera Public Limited Company Ordinary Shares
KAL
| $2.45M | 0.04% |
+18,393
| New | +$4.97M |
|
123
Take-Two Interactive
TTWO
$39.9B
| $2.4M | 0.04% |
+22,000
| New | +$2.73M |
|
124
Puma Biotechnology
PBYI
$491M
| $2.37M | 0.04% |
1,000,000
-500,000
| -33% | -$1.46M |
|
|
SDIG
125
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
| $2.37M | 0.04% |
+227,435
| New | +$4.42M |
|
Similar funds
MWM
BP
FWCM
SC
SFM
EHC
BIM
WF
Armistice Capital's Q3 2022 Portfolio in Review
As of Q3 2022, Armistice Capital held 248 positions worth $5.76B, up 0.57% from $5.73B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Armistice Capital deployed $188M of net new capital in Q3 2022, opening 70 new positions and adding to 46 existing holdings. Its largest new stake was GSK: 3,600,000 shares worth $106M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $46.6M trimmed.
- Armistice Capital's largest Q3 2022 buy was GSK: 3,600,000 shares worth $106M.
- Armistice Capital added most to Freshpet in Q3 2022, an estimated $91.3M increase.
- Armistice Capital's biggest Q3 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $46.6M.
- Armistice Capital fully exited Dollar General in Q3 2022, selling an estimated $75.6M.
- Armistice Capital's ten largest holdings make up 50% of its $5.76B portfolio in Q3 2022.
- Armistice Capital opened 70 new positions and closed 50 in Q3 2022.
- Armistice Capital's portfolio value rose 0.57% quarter-over-quarter to $5.76B.
Based on Armistice Capital's 13F filing for Q3 2022, filed 14 Nov 2022.